Issue | Pharma's Almanac

Current Issue: Q4 2016

The Role of Innovative Technologies

Also In This Issue

Innovation is at the heart of the pharmaceutical industry. Researchers develop innovative approaches to understanding biological processes, including the identification of potential new targets for which novel drug substances are developed. New technologies are continually being introduced to improve the efficiency and productivity of discovery, development and manufacturing activities. And all the while, the goal […]

Q: What is Your Perception of the State of Serialization in Your Sector of the Pharma Industry?

Mark Hammond, Commercial Director, Aesica A: With serialization legislation already enforced in markets such as Brazil and China, and set to be fully enforced in the EU by February 2019, we’ve seen a very varied state of preparedness for serialization across the CMO sector. The ability to support drug companies to meet this complex regulatory […]

Cultivating a Proactive Quality Culture

Preventing patient risk is perhaps the most important goal for any pharmaceutical manufacturer. The quality of a drug substance or product is directly linked to where and how it’s made. As a result of the gravity of production, management must ensure that process variation is eliminated, consistent quality is guaranteed and there are no threats […]

Shaping the Conversation – Bringing Voice & Value

Originally born of a discussion about our Nice Insight research (now going into our eighth year) and how we could align our customers’ voices in an open forum, we published our first supplement under American Pharmaceutical Review in the spring of 2015. As of this print issue, we have had the honor of bringing 66 […]

Finding The Ideal Partner for Your Next Biotherapeutic

Specialty and biological drugs that require complex manufacturing, such as fermentation, are projected to account for half of the pharmaceutical industry by 2020,1 with facilities that develop and manufacture many of these compounds looking to expand current operations by 25% in the same time frame.2 Biopharmaceutical companies with portfolios heavily staked in the development of […]

Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services

In the rapidly growing but highly competitive biopharmaceutical market, drug innovators require the support of biologics contract manufacturers that offer more than just additional capacity. They must be financially stable, have an in-depth understanding of market needs and regulatory requirements, manufacturing expertise for right-first-time project implementation and a commitment to continuous improvement across all activities. […]

New Strategies Required to Meet Changing Needs in the Analytical Services Market

The pharmaceutical analytical services market is growing, but the competition is heating up. (Bio)pharmaceutical companies rely on analytical service providers to provide high-quality support for core testing needs so they can best leverage their internal resources. To meet industry needs for high-quality, rapid, cost-effective testing services, BioDuro is now offering clients an enhanced strategy […]

Seeking Quality Deals: Consolidation and Acquisition

Nice Insight’s Virtual Panelists explore the deal-structuring shift in the pharmaceutical market from an investor perspective. Consolidation has been a watchword for the pharmaceutical industry in recent years. Major pharmaceutical companies are looking to enhance their pipelines through the acquisition of competitors with complementary portfolios in terms of treatment classes, geographic markets or other synergies. […]

Pharmaceutical Packaging: Differentiation Equates to Brand Loyalty

Nice Insight’s Virtual Panelists share their thoughts about the integral role that safer, simpler and smarter packaging plays in a compound’s success. Of the upwardly climbing global pharmaceutical packaging market, which was valued at close to $52 billion in 2014 and is expected to reach upwards of $80 billion by 2020,1 plastic bottle and parenteral […]

Past Issues

View all Past Issues

The Next-Generation Issue

View Issue »

Issue #2 | Volume #4 | Q2 2018

Future Pharma Partner Models

View Issue »

Issue #3 | Volume #3 | Q3 2017

The Business Development Issue

View Issue »

Issue #1 | Volume #5 | Q1 2019

The Innovation Issue

View Issue »

Issue #4 | Volume #6 | Q4 2020